Multidisciplinary management of posterior fossa dural arteriovenous fistula: A single-center experience.


Journal

Neuro-Chirurgie
ISSN: 1773-0619
Titre abrégé: Neurochirurgie
Pays: France
ID NLM: 0401057

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 26 05 2022
revised: 04 08 2022
accepted: 21 09 2022
pubmed: 20 12 2022
medline: 25 1 2023
entrez: 19 12 2022
Statut: ppublish

Résumé

The management of posterior fossa dural arteriovenous fistulas (pfDAVFs) is challenging. Here, we show how multidisciplinarity leads to their successful management, even in complex cases. All pfDAVFs managed from 2010 to 2019 at our center were reviewed. The preoperative clinical and radiological characteristics, their management and the occlusion rate were retrieved. The radiological and functional outcomes were retrieved at discharge and last follow-up (FU). n=27 patients were included (6 females, mean age: 61-years-old, mean FU: 22.5 months). n=8 patients presented with cerebral hemorrhage. Among patients with ruptured pfDAVFs, n=7 had headache, n=4 had ataxia, and n=2 had impaired level of consciousness. In the unruptured group N (n=19), n=7 patients had headache, n=6 patients had focal neurological deficit, n=4 patients had tinnitus, n=3 (had ataxia, and one presented with seizure. n=24 patients were treated by endovascular therapy (EVT), n=2 patients were treated by microsurgery (MS) and n=1 patient was managed with a combined approach. Re-treatment was necessary in n=6 patients. n=24 patients showed total exclusion at last FU. n=2 patients died during the first 30 days; n=1 patient died during FU. While EVT should be advocated as the first line therapy whenever possible, MS should not be banned from the treatment armamentarium. Neurosurgeons must be able to achieve direct surgical occlusion when the angioarchitecture speaks against EVT.

Identifiants

pubmed: 36535082
pii: S0028-3770(22)00163-1
doi: 10.1016/j.neuchi.2022.101389
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101389

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

J Tinois (J)

Pôle des neurosciences, service de neurochirurgie, centre hospitalier universitaire de Rennes, Rennes, France; Faculté de médecine, université de Rennes 1, Rennes, France; Inserm UMR 1099 LTSI, laboratoire du traitement de signal, unité médicis, université de Rennes 1, Rennes, France.

G Danassegarane (G)

Pôle des neurosciences, service de neurochirurgie, centre hospitalier universitaire de Rennes, Rennes, France.

M Bretonnier (M)

Pôle des neurosciences, service de neurochirurgie, centre hospitalier universitaire de Rennes, Rennes, France; Faculté de médecine, université de Rennes 1, Rennes, France.

J-C Ferré (JC)

Faculté de médecine, université de Rennes 1, Rennes, France; Service de radiologie et d'imagerie médicale, centre hospitalier universitaire de Rennes, Rennes, France.

X Morandi (X)

Pôle des neurosciences, service de neurochirurgie, centre hospitalier universitaire de Rennes, Rennes, France; Faculté de médecine, université de Rennes 1, Rennes, France; Inserm UMR 1099 LTSI, laboratoire du traitement de signal, unité médicis, université de Rennes 1, Rennes, France.

M V Corniola (MV)

Pôle des neurosciences, service de neurochirurgie, centre hospitalier universitaire de Rennes, Rennes, France; Faculté de médecine, université de Rennes 1, Rennes, France; Faculté de médecine, université de Genève, Geneva, Switzerland; Inserm UMR 1099 LTSI, laboratoire du traitement de signal, unité médicis, université de Rennes 1, Rennes, France. Electronic address: marcovincenzo.corniola@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH